Search Results for "fluid"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for fluid. Results 71 to 80 of 206 total matches.

Ektachem DT Analyzers For The Office

   
The Medical Letter on Drugs and Therapeutics • Dec 30, 1988  (Issue 782)
reference fluid at the same time. CALIBRATION AND CONTROLS — Control sera, which are provided, should ...
(Kodak) perform clinical chemistry tests using desk-top instruments, microliter samples and postage-stamp-sized analytical slides containing dry reagents layered on clear polyester and mounted in plastic. The system requires no wet reagents, except for electrolyte determinations, and is designed to require a minimum amount of training to operate. A single analysis takes about five minutes.
Med Lett Drugs Ther. 1988 Dec 30;30(782):119-20 |  Show IntroductionHide Introduction

Ifosfamide and Mesna

   
The Medical Letter on Drugs and Therapeutics • Nov 03, 1989  (Issue 804)
marrow restoration. At least two liters of oral or IV fluid should be given daily. The manufacturer ...
Ifosfamide (Ifex - Mead Johnson), a synthetic analog of cyclophosphamide (Cytoxan; and others), has been approved by the US Food and Drug Administration (FDA) for concurrent use with other drugs in third-line chemotherapy of metastatic germ-cell testicular cancer. Given concomitantly, a synthetic sulfhydryl compound known as mesna (Mesnex - Asta) acts in the urine to detoxify metabolites of ifosfamide that cause hemorrhagic cystitis (H Burkert, Cancer Treat Rev, 10 suppl A:175, 1983). Ifosfamide and mesna are available together from Bristol-Myers Oncology Division.
Med Lett Drugs Ther. 1989 Nov 3;31(804):98-9 |  Show IntroductionHide Introduction

Samarium-153 Lexidronam for Painful Bone Metastases

   
The Medical Letter on Drugs and Therapeutics • Aug 29, 1997  (Issue 1008)
over a period of one minute. The patient should ingest a minimum of 500 ml of fluids before injection ...
Samarium-153 lexidronam (Quadramet - Dupont Pharma) has been approved by the FDA for relief of pain in patients with osteoblastic bone metastases. Strontium-89 (Metastron) has been available for several years for this indication (Medical Letter, 35:102, 1993).
Med Lett Drugs Ther. 1997 Aug 29;39(1008):83-4 |  Show IntroductionHide Introduction

Rifapentine--A Long-Acting Rifamycin for Tuberculosis

   
The Medical Letter on Drugs and Therapeutics • Feb 26, 1999  (Issue 1047)
-orange discoloration of body fluids and stains contact lenses. In clinical trials with isoniazid, rates ...
Rifapentine, a long-acting analog of rifampin developed in the 1960's, has received an accelerated approval from the FDA for oral use, with at least one other drug, in the treatment of pulmonary tuberculosis.
Med Lett Drugs Ther. 1999 Feb 26;41(1047):21-2 |  Show IntroductionHide Introduction

An Expanded Pneumococcal Vaccine (Prevnar 13) for Infants and Children

   
The Medical Letter on Drugs and Therapeutics • Aug 23, 2010  (Issue 1345)
, sickle cell disease, asplenia, cochlear implant, cerebrospinal fluid leak) should receive 2 doses ...
The FDA has licensed a 13-valent conjugate pneumococcal vaccine (PCV13; Prevnar 13 – Pfizer) for the prevention of invasive pneumococcal disease (IPD) in infants and children <6 years old. It replaces Prevnar (PCV7). An unconjugated 23-valent polysaccharide vaccine (PPSV23; Pneumovax 23 – Merck) is FDA-approved for use in adults.
Med Lett Drugs Ther. 2010 Aug 23;52(1345):67-8 |  Show IntroductionHide Introduction

Testosterone Topical Solution (Axiron) for Hypogonadism

   
The Medical Letter on Drugs and Therapeutics • Jul 11, 2011  (Issue 1368)
of INR or prothrombin time is recommended if androgens and anticoagulants are used concurrently. Fluid ...
The Medical Letter recently reviewed a topical gel formulation of testosterone (Fortesta) for treatment of hypogonadism in men. A topical testosterone replacement product for application to the axilla, Axiron (Lilly) solution, has now become available for the same indication. This site of application presumably minimizes the risk of transferring the drug to a family member or sexual partner.
Med Lett Drugs Ther. 2011 Jul 11;53(1368):54-5 |  Show IntroductionHide Introduction

Pioglitazone/Metformin (Actoplus met)

   
The Medical Letter on Drugs and Therapeutics • Jan 30, 2006  (Issue 1227)
, can cause or exacerbate fluid retention, possibly through an effect on renal sodium excretion, 7 ...
For patients with diabetes poorly controlled with a single oral drug, addition of a second drug with a different mechanism can be helpful. A fixed-dose combination (Actoplus met - Takeda) of two widely used antihyperglycemic drugs, the thiazolidinedione pioglitazone (Actos) and the biguanide metformin (Glucophage, and others), has been approved by the FDA for management of type 2 diabetes. It is indicated for patients already being treated with both pioglitazone and metformin or as second-line therapy for those not adequately controlled with either metformin or pioglitazone alone....
Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11 |  Show IntroductionHide Introduction

The Cervical Cap

   
The Medical Letter on Drugs and Therapeutics • Oct 07, 1988  (Issue 776)
of menstrual fluids. INSTRUCTIONS — The package insert indicates that the patient should fill the cap about ...
The US Food and Drug Administration recently approved the marketing of a cervical cap (Prentif Cavity-Rim Cervical Cap - Lamberts Ltd, England), a contraceptive device that has been used in one form or another for many years (JP Koch, Contraception, 25:161, 1982). The cap is being distributed in the USA and Canada by Cervical Cap (CxC), Ltd, PO Box 38003-292, Los Gatos, CA 95031, telephone 408-358-6264; the distributor will make the caps available only to practitioners who have attended training seminars.
Med Lett Drugs Ther. 1988 Oct 7;30(776):93-4 |  Show IntroductionHide Introduction

ACE Inhibitors for Congestive Heart Failure

   
The Medical Letter on Drugs and Therapeutics • Oct 21, 1988  (Issue 777)
other oral agent and are the only drugs that can control fluid retention. Diuretics alone, however, often ...
The angiotensin-converting enzyme (ACE) inhibitors captopril (Capoten - Squibb) and enalapril (Vasotec - Merck) are now widely used to treat chronic congestive heart failure that has not responded adequately to digitalis and diuretics (Medical Letter, 30:13, Jan 29, 1988). Recently, some cardiologists have debated whether ACE inhibitors should also be used as first-line agents for treatment of this condition (WW Parmley et al, J Am Coll Cardiol, 12:265, July 1988).
Med Lett Drugs Ther. 1988 Oct 21;30(777):97-8 |  Show IntroductionHide Introduction

Cefmetazole Sodium (Zefazone)

   
The Medical Letter on Drugs and Therapeutics • Jul 13, 1990  (Issue 822)
of cefmetazole in tissues and unobstructed bile, but no data are available on cerebrospinal-fluid concentrations ...
Cefmetazole sodium (Zefazone - Upjohn), a second-generation parenteral cephalosporin, was recently marketed in the USA for intravenous (IV) treatment of various infections caused by susceptible organisms. Like cefotetan (Cefotan), cefamandole (Mandol), cefoperazone (Cefobid), and moxalactam (Moxam), cefmetazole contains a methylthiotetrazole group that has been associated with prothrombin deficiency.
Med Lett Drugs Ther. 1990 Jul 13;32(822):65-6 |  Show IntroductionHide Introduction